Monthly Prescribing Reference

VESTIGE Asthma Trial Uses Functional Respiratory Imaging to Assess Dupilumab

The phase 4 VESTIGE trial is using functional respiratory imaging to assess the effect of dupilumab on lung function and airway volume in asthma. The following article features coverage from the ...
Business Wire

International Clinical Studies Show Why Diagnosing Early Signs of Acute Respiratory Distress Syndrome in COVID-19 Patients Key to Managing Infection

NEW YORK--(BUSINESS WIRE)--In the race to find treatment options for COVID-19 patients, physicians and clinicians began treating the virus as they would viral pneumonia. But, new research from Fluidda ...
technologynetworks

FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA

FLUIDDA develops proprietary Functional Respiratory Imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the ...
Business Insider

FDA Clears Fluidda's Broncholab Platform for Use in Clinical Practice

LOS ANGELES, March 11, 2020 /PRNewswire/ -- The US Food and Drug Administration provided market clearance to Fluidda for its Broncholab platform. Broncholab provides a number of Functional Respiratory ...
Medscape

Dupilumab Boosts Lung Function in Patients With Type 2 Asthma

Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients with moderate to severe type 2 ...

4DMedical GSK Lung Imaging Deal And What It May Mean For Investors

DMedical (ASX:4DX) has signed a contract with GlaxoSmithKline to supply quantitative lung imaging analytics. The agreement focuses on using 4DMedical’s technology in GSK’s drug development programs.